American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.
about
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal MedicinePrediction of Cancer Drug Resistance and Implications for Personalized MedicinePrecision medicine for cancer with next-generation functional diagnosticsRecent applications of chemosensitivity tests for colorectal cancer treatmentSpecial Technologies for Ex Vivo Analysis of CancerIdentification of drug combinations containing imatinib for treatment of BCR-ABL+ leukemiasPersonalized chemotherapy profiling using cancer cell lines from selectable miceIn vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index.Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.A health services research agenda for cellular, molecular and genomic technologies in cancer care.Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.Chemotherapy as a component of multimodal therapy for gastric carcinomaEvaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective studyStratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer.Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.Current status of methods to assess cancer drug resistance.Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay.Prediction of individual response to anticancer therapy: historical and future perspectivesTargeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.Three-dimensional organotypic culture: experimental models of mammalian biology and disease.In vitro adenosine triphosphate based chemotherapy response assay in gastric cancer.Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot studyUse of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian CancerBreast cancer gene expression profiling: clinical trial and practice implications.Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences.Promises and pitfalls in the prediction of antiepidermal growth factor receptor activity.Marketing of personalized cancer care on the web: an analysis of Internet websitesExploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial)Medical treatment of pancreatic cancer.Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancerNovel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patient.Parameters for individualizing systemic therapy in non-small cell lung cancerHeterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication.Neoadjuvant systemic treatment of breast cancer.Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.Peek before you treat? Is it a fantasy or reality?Drug sensitivity testing platforms for gastric cancer diagnostics.Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement
P2860
Q26741336-2E9EF47A-EA96-4E78-AA87-C19ECCC9ECEBQ26770581-A73D0376-A95D-4F65-8D94-C92E663C3002Q26780232-3963B398-75E2-4AFA-9B69-8542698BBA2BQ26851075-8DA91DCE-1680-4C76-A43D-BA0141D4A547Q28087644-6AFB2597-02BF-4307-B8C1-4B4C0DCFBD97Q28540799-36439778-3025-4DDB-A413-0380B5130B3CQ30538234-B4385C63-179F-490F-8BA7-7EE02FAB0ED7Q30665874-02AAD0FC-C29E-4223-B560-8DB1CC438BF4Q33586020-F3756169-207B-4F75-B293-7CDD57A8B889Q33749983-CEE3DD71-F606-456B-983B-80F2AD32BDF6Q33807207-E1772B7D-51FE-4C18-8901-55724356977EQ33814552-9D2DE6CC-9ED6-4948-8A67-8A495386ED25Q33867249-B03BE716-F2EC-4BEF-A25F-89A6B38DBC44Q34113564-035F3790-415E-4A52-967A-4EA4C664A4C5Q34216314-F65D35CD-D9F8-4DC9-AE7A-8DF2136B4288Q34256053-D5719F90-9F03-4E6D-A780-B4FA7A557FF6Q34779180-DFAA187A-AB26-44E1-A4A2-E057CF698D00Q35023385-37C39B01-12FD-4D6E-8A03-D17C63F39C03Q35024682-590E32B3-4E36-4B2C-BD90-13FFEF34EE9FQ35088311-0B6EFC48-C7CE-40C5-B246-31456FD015DCQ35155660-20856D3D-CCB5-441C-A879-C244370E64F3Q35481418-9BF492CE-46F2-4A5E-B9A0-8B1DB05DE35EQ35675900-73CAFE20-DC9F-4C41-8734-7D7B89ABA771Q35715271-4AF51D72-8A29-4E16-B6BA-6F9CD2295B9AQ36050579-1522CE96-EE08-41E0-AEB3-CE5282802C88Q36117934-3E731EC1-79CB-4728-826D-C216B4CB2CEEQ36235591-B5F5AD9F-259B-4B64-AE93-1370F051A5F5Q36770241-F2DD3DC6-37F4-4807-884C-DE1BA7E2A49EQ36778096-6FAF595C-303D-4E2A-A156-47671AC25A1CQ36788494-BEB003EE-2E08-4F64-997B-283735FC410FQ37248561-78B4C3C5-9EC3-40A3-87B6-FBD77C0E0909Q37347521-3EDF171E-E104-422F-9121-ADE4905A865FQ37398845-FE5B905A-E742-4C90-9873-7327E64592B3Q37400987-F49F1051-DA0B-4249-BCAD-00AFA29DDA5BQ37845317-91C88BD4-8983-4ECC-97DC-0FBDB1330757Q37888461-56CF00DB-5C46-434C-8C5F-FE77C3CA9031Q38236904-EFABE9B6-7D83-47DB-AA6F-B30BA830BE2EQ38364708-C7ACAAFD-A1AD-4CD8-8002-C947D86F2124Q38633116-FCA40313-0ED1-45E5-8174-805BB54D6EF9Q38842969-948B6A1B-AA58-481C-93A2-25D0F239F880
P2860
American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
type
label
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
prefLabel
American Society of Clinical O ...... itivity and resistance assays.
@ast
American Society of Clinical O ...... itivity and resistance assays.
@en
P2093
P356
P1476
American Society of Clinical O ...... itivity and resistance assays.
@en
P2093
ASCO Working Group on Chemotherapy Sensitivity and Resistance Assays
Daniel D Von Hoff
David J Samson
Deborah Schrag
Harinder S Garewal
Harold J Burstein
Mark R Somerfield
P304
P356
10.1200/JCO.2004.05.065
P407
P577
2004-08-02T00:00:00Z